Inpart Deal
inpart.io
- Web
- Browser extension
6.1 Club score Visit inpart.io
What the maker publishes
- Adoption
- Inpart states that 70% of top pharma use Inpart Deal to power their partnering operations. source
- Agreement scanning
- Users can highlight agreement text to auto-fill fields, create tasks, and extract obligations or milestones. source
- AI data limit
- Inpart says the in-app AI assistant has no access to the customer's internal data. source
- Conference sync
- Deal syncs with over 20 major biopharma partnering conferences, including BIO Convention and J.P. Morgan, so meetings can be imported. source
- Connect integration
- Results from Inpart Connect campaigns are created in Inpart Deal without manual data entry. source
- Data enrichment
- Deal can pull real-time insights from Evaluate Pharma, Cortellis, PatSnap, and other sources into evaluations. source
- Encryption
- Customer data is encrypted at rest and in transit, and each customer has a dedicated database. source
- GDPR
- Inpart stores customer data in Europe and says that supports compliance with the GDPR. source
- Hosting
- The cloud solution is hosted in an ISO 27001-certified datacenter in Geneva, with a synchronized backup datacenter in Paris. source
- In-app AI
- An in-app AI assistant provides insights across patents, pipelines, and trials using PatSnap's biopharma-trained LLM. source
- Outlook add-in
- An Outlook add-in lets users store and share emails and update or retrieve information from Deal. source
- Positioning
- Inpart describes Deal as its partnering CRM, tailored to the biopharma sector. source
- Support
- Dedicated Customer Success Managers support customers from the first demo through rollout, scaling, and later adjustments. source
- What it does
- Inpart Deal unifies a partnering team's data, documents, and decisions from first contact through the final milestone. source
- Who it is for
- Biotechs and top pharma companies use Inpart Deal to track, manage, and report on deal activities. source
Checked against the maker's pages on 14 Nov 2026.